The efficacy of SARS-CoV-2 vaccination in the Elderly: a systemic review and Meta-analysis
XH Yang, WJ Bao, H Zhang, SK Fu, HM Jin - Journal of General Internal …, 2023 - Springer
Background Given the reduced immune response to vaccines in older populations, this
study aimed to evaluate the efficacy of COVID-19 vaccinations and its impact on …
study aimed to evaluate the efficacy of COVID-19 vaccinations and its impact on …
Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathology
Age is a major risk factor for severe coronavirus disease 2019 (COVID-19), yet the
mechanisms behind this relationship have remained incompletely understood. To address …
mechanisms behind this relationship have remained incompletely understood. To address …
Heterologous booster with BNT162b2 induced high specific antibody levels in CoronaVac vaccinees
LC Masson, CP Servian, VH Jardim, D Dos Anjos… - Vaccines, 2023 - mdpi.com
Immune responses after COVID-19 vaccination should be evaluated in different populations
around the world. This study compared antibody responses induced by ChAdOx1 nCoV-19 …
around the world. This study compared antibody responses induced by ChAdOx1 nCoV-19 …
Investigating incidence of and factors associated with SARS-CoV-2 infection over a nine-month period in a highly-vaccinated healthcare worker cohort
L Townsend, L Marron, K O'Brien… - … Journal of Medicine, 2024 - academic.oup.com
Abstract Background Healthcare workers (HCWs) are at increased risk of SARS-CoV-2
infection. This risk persists despite the implementation of mitigating factors, including …
infection. This risk persists despite the implementation of mitigating factors, including …
Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant …
K Kawashiro, R Suzuki, T Nogimori, S Tsujino… - Scientific Reports, 2024 - nature.com
Abstract Although the mRNA SARS-CoV-2 vaccine has improved the mortality rate in the
general population, its efficacy against rapidly mutating virus strains, especially in kidney …
general population, its efficacy against rapidly mutating virus strains, especially in kidney …
Safety, immunogenicity, and efficacy of an mRNA COVID-19 vaccine (RQ3013) given as the fourth booster following three doses of inactivated vaccines: a double …
Background Heterologous vaccine schedules have been recommended to provide superior
immunity and protection against emergent SARS-CoV-2 variants of concern. We aimed to …
immunity and protection against emergent SARS-CoV-2 variants of concern. We aimed to …
Safety and immunogenicity of a heterologous booster with an RBD virus-like particle vaccine following two-or three-dose inactivated COVID-19 vaccine
X Yong, J Liu, Y Zeng, J Nie, X Cui… - Human Vaccines & …, 2023 - Taylor & Francis
ABSTRACT LYB001 is an innovative recombinant SARS-CoV-2 vaccine that displays a
repetitive array of the spike glycoprotein's receptor-binding domain (RBD) on a virus-like …
repetitive array of the spike glycoprotein's receptor-binding domain (RBD) on a virus-like …
[HTML][HTML] Humoral immune response in people living with HIV after administration of SARS-CoV-2 vaccine CoronaVac or BNT162b2 or CoronaVac/BNT162b2 booster …
Background The evidence of SARS-CoV-2 vaccine effectiveness in people living with HIV
(PLWH) is limited. This study evaluated the humoral immune response to …
(PLWH) is limited. This study evaluated the humoral immune response to …
[HTML][HTML] Host-Microbe Multiomic Profiling Reveals Age-Dependent COVID-19 Immunopathology
Age is a major risk factor for severe coronavirus disease-2019 (COVID-19), yet the
mechanisms responsible for this relationship have remained incompletely understood. To …
mechanisms responsible for this relationship have remained incompletely understood. To …
Comparison of humoral immune response in heterologous and homologous COVID-19 booster vaccine groups using CoronaVac and mRNA-based BNT162b2 …
Background: Heterologous COVID-19 booster vaccination is an alternative strategy to
homologous vaccination, especially in developing countries, due to shortages, delays, or …
homologous vaccination, especially in developing countries, due to shortages, delays, or …